Biotech News

Veradigm Product Portfolio Achieves HITRUST i1 Certification

Veradigm (MDRX)VeradigmCompany update

Independent validation confirms rigorous, continuously assessed security controls protecting sensitive healthcare data across a broad set of Veradigm solutions CHICAGO --(BUSINESS WIRE)--Oct. 21, 2026-- Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data, clinical, and revenue cycle

Related news

Veradigm

Veradigm is a healthcare information and analytics company focused on software, data, and workflow tools for providers and life-sciences customers. Its business is more about information infrastructure than therapeutic innovation.

Recent company news

Stock data

Close
4.95 USD
Market cap
—
Exchange
NASDAQ
Sector
Biopharma
Location
United States